Factors predicting treatment compliance among hypertensive patients in an urban area

In chronicle diseases such as hypertension which requires permanent drug use and regular control, the maladjustment with the treatment is one of the most significant obstacles for ensuring an efficient blood pressure. This study aimed to measure compliance with antihypertensive therapy in a group of patients in an urban area and to identify variables associated with compliance. This study is a cross-sectional research which is conducted to the patients diagnosed as having hypertension and over 40 years old (total 535 hypertensive patient) who were registered at İzmir, Konak Emine Bagcier Health Care Center at the date of January 1st 2014 (total 3594 patient). Sample, when the prevalence is taken as 31%, is composed of 300 hypertensive patients who have a power to represent the population with a deviation of 5%. Sample units are individuals. The data were collected through face-to-face interviews using a questionnaire form. In the questionnaire, the socio-demographic features of the patients, their attitudes, knowledge and behaviours towards hypertension disease and Antihypertensive treatment Adjustment Questionnaire were questioned. According to the 8-question questionnaire scale of Morisky, while 74% of the patients was moderately compatible, 22.7%was determined to be incompatible for the treatment. Following the search, no relation was found between age, marital status, businesseducation status and socioeconomic level and conformity. It was stated that treatment conformity of the people who had true and wide information about hypertension and who were informed by the doctor, who showed the behaviors of quitting cigarette, limiting salt and fat and who had a regular sleep pattern was better. It was pointed out that the greatest obstacle for regular monitoring was resulted from organizational problems about being unable to reach the treatment. Although it was not thought that diseases of the many patients were not in control, patients whose diagnosis and treatments were regulated in the second step were more compatible. Perception of the patient that her/his hypertension is under control is one of the leading factor for drug compliance/medical treatment adherence. Major element to improve the compliance is experiencing regular physician visits. In other words, regular control of a physician is essential. Finally, adoption of health promoting habits such as cessation of smoking is associated to medical treatment adherence. Medical treatment adherence may also be regarded as a part of health promotion

PDF

___

1. WHO-ISH Guidelines Subcommittee. 1999 WHO International Societyof Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17(2):151-83.

2. Altun B, Arıcı M, Nergizoğlu G, Derici Ü, Karatan O,Turgan Ç, Sindel Ş, Erbay B, Hasanoğlu E, Çağlar S,and for the Turkish Society of Hypertension and Renal Diseases. Prevalence, awareness, treatment and controlof hypertension in Turkey (thePatenT study) in 2003. JHypertens. 2005;23(10):1817-23.

3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.

4. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs. Lancet. 2000;356(9246):1955-64.

5. Kabakcı G, Abacı A, Ertaş FS, Özerkan F, Erol Ç, Oto1 A. The risk for stroke and differences among geographical regions regarding this risk in hypertensive patients in Turkey: a hospital-based, crosssectional, epidemiological questionnaire (THİNK)* study) Arch Turk Soc Cardiol. 2006;34(7):395-405.

6. 6.Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens. 2003;21:1199–205.

7. Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, Mancia G. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–8.

8. Koçkaya G, Wertheimer A. Can we reduce the cost of illness with more compliant patients? An estimation of the effect of 100% compliance with hypertension treatment. J Pharm Pract. 2011;24(3):345-50.

9. Arıcı M, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, Sindel S, Erbay B, Hasanoğlu E, Cağlar S; Turkish Society of Hypertension and Renal Diseases. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005;23(10):1817-23.

10. Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, de Lyra Junior DP. Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and Blood Pressure Control. Arq Bras Cardiol. 2012 (in Press).

11. De las Cuevas C, Peñate W. Psychometric properties of the eightitem Morisky Medication Adherence Scale. Int J Clin Health Psychol. 2015;15:121-9.

12. Demirezen E. Using antihypertensive drugs in Turkey and in Germany Adherence to drug treatment in Turks. Istanbul University Health Sciences Institute, Nursing Program; PhD Thesis, Istanbul, 2006.

13. Hatice Mert, Nilgün Özçakar, Emel Kuruoğlu A Multidisciplinary Special Study Module Reasrch: Treatment Compliance Of Patients With Hypetension;TJFM&PC. 2011;15(1):7-12. 14. Steiner JF1

, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, Tavel HM, Havranek EP, Davidson AJ, Magid DJ, Estacio RO. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009;2(5):451-7.

15. Topuzoğlu A, Hıdıroğlu S, Önsüz MF, Polat G. Missed opportunities for chronic diseases prevention in a primary health care center in Istanbul. TAF Prev Med Bull. 2011;10(6):665-74.

16. Turkay M, Senol Y, Alimoglu MK, Aktekin MR, Deger N. Missed opportunities for coronary heart disease diagnoses: primary care experience. Croat Med J. 2007;48(3):362-70.

17. Kozan O, RiskMan Study Group. An observational study to evaluate the clinical practice ofcardiovascular risk management among hypertensive patients in Turkey. Turk Kardiyol Dern Ars. 2011;39(6):445-55.

18. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B.. Effectiveness of interventions to improve patient compliance: a metaanalysis. Med Care. 1998;36(8):1138-61.

19. Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189-99.

20. Karaeren H, Yokuşoğlu M, Uzun S, Baysan O, Köz C, Kara B, Kirilmaz A, Naharci I, Pinar M, Yilmaz MB, Uzun M. The effect of the content of the knowledge on adherence to medication in hypertensive patients. Anadolu Kardiyol Derg. 2009;9(3):183-8.

21. Öngen Z. A difficult social problem to solve hypertension. Clinical Development. 2005;18(2):4-7.

22. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479-86.

23. Mo L, He QY. [Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials]. Zhonghua Yi Xue Za Zhi. 2007;87(17):1177-80.

24. Cheung YY, Tai BC, Loo G, Khoo SM, Cheong KY, Barbe F, Lee CH. Screening for obstructive sleep apnea in the assessment of coronary risk. Am J Cardiol. 2017;pii: S0002-9149(16)31999-3.

25. Ogedegbe GO, Schoenthaler AM, Richardson T, Lewis L, Belue R, Espinosa E, Spencer J, Allegrante JP, Charlson ME. An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design. Contemp Clin Trials. 2007;28(2):169-81.

26. Espinosa García J, Martell Claros N, Llerena Ruiz A, Fernández Bergés Gurrea D. Pharmacological compliance in the treatment of arterial hypertension. A review of studies published between 1975 and 2011. Semergen. 2012;38(5):292-300.

27. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12(3):243-9.

28. Gün Y, Korkmaz M, Treatment compliance and quality of life of hypertensive patients Hypertension, Compliance, Quality of Life Dokuz Eylul University School of Nursing Electronics Review DEUHFED. 2014;7(2):98-108.

29. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens. 2003;21(6):1199–205.

30. Natarajan N1 , Putnam W, Van Aarsen K, Beverley Lawson K, Burge F, Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 2013;59(2):93-100.

31. Cingil D, Delen S, Aksuoğlu A. Evaluation of compliance and level of knowledge of patients with hypertension living in Karaman city center, Turkey. Arch Turk Soc Cardiol. 2009;37(8):551-6.

32. Amira CO, Okubadejo NU. Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians. Niger Postgrad Med J. 2007;14(4):325-9.

33. Uzun S, Kara B, Yokuşoğlu M, Arslan F, Yilmaz MB, Karaeren H. The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations; Anadolu Kardiyol Derg. 2009;9(2):102-9.

34. National Institutes of Health: Working Group report on primary prevention of hypertension. Poul K.Whelton.MD.M.Sc.Proffesor of Epidemiology and Medicine Dırector, Welch Center for Prevention Epidemiology and Clinical Reaserch The Jobs Honkins Medical İnztituations Boltimore, Maryland. NIH Pub. no: 93-2669, 1993. https://www.nhlbi.nih.gov/files/docs/resources/heart/pphbp.pdf access date 20.12.2016

35. Grassi G. Definition and Classification of Hypertension. Kozan Ö. Hypertension Basis and Application. 1st edition, Istanbul: European Medicine Bookshop Ltd. 2009;15-22.

36. Erdine S. Compliance with the treatment of hypertension: the potential of combination therapy. J Clin Hypertens (Greenwich). 2010;12(1):40-6.